7Baggers
 Equillium Reports Q3 Loss Amid Strategic Focus  TipRanks Fri, 14 Nov 2025 04:40:25 GMT
 Equillium Narrowed Its Losses And Topped Expectations  Finimize Fri, 14 Nov 2025 00:12:40 GMT
 equillium narrowed its losses and topped expectations  Finimize Thu, 13 Nov 2025 23:13:03 GMT
 published on: 2025-11-10 07:20:31  newser.com Mon, 10 Nov 2025 13:20:31 GMT
 equillium shares plunge amid investor skepticism  AD HOC NEWS Wed, 05 Nov 2025 16:43:04 GMT
 equillium (eq) expected to announce earnings on wednesday  MarketBeat Wed, 05 Nov 2025 12:08:59 GMT
 Equillium to Participate in Upcoming Investor Conferences  GlobeNewswire Tue, 04 Nov 2025 13:30:00 GMT
 equillium (nasdaq:eq) trading up 3.6% - what's next?  MarketBeat Sat, 01 Nov 2025 09:22:11 GMT

Equillium, Inc
(NASDAQ:EQ) 

EQ stock logo

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune ...

Founded: 2017
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends